Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Pixel-Level RGBT Fusion Tracking via Heterogeneous Multi-Expert Distillation and Decoupled Representation Learning.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Exploration of the Clinical Assessment and Prognostic Value of Society for Cardiovascular Angiography and Intervention Shock Staging in Patients With Acute Myocardial Infarction and Cardiogenic Shock on Veno-arterial Extracorporeal Membrane Oxygenation Support.

Reviews in cardiovascular medicine·2026
Same author

Unveiling the Power of Multi-Modal Template Update in RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

ECMO management in cardiogenic shock-specialized versus non-cardiogenic shock-specialized centers: a registry-based analysis.

BMC anesthesiology·2025
Same author

Clinical study of area-decreasing technique and conventional post-closure technique for V-A ECMO weaning application: study protocol of a randomised controlled trial.

BMJ open·2025
Same author

AFTER: Attention-Based Fusion Router for RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025

関連する実験動画

Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

複合的な高リスクPCI中の予防的VA-ECMO:ランダム化制御試験

Chenliang Pan1, Youqi Zhu1, Jing Zhao1

  • 1The First School of Clinical Medicine of Lanzhou University, Lanzhou, China; Heart Center, The First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Cardiovascular Diseases, Lanzhou, China.

JACC. Advances
|August 22, 2025
PubMed
まとめ

高リスクの皮膚経冠動脈介入 (PCI) 中の予防性静脈動脈外膜酸素化 (VA- ECMO) は,生命を脅かす合併症を大幅に軽減し,アウトカムを改善しました. このアプローチは,複雑なPCI患者にとってより安全な戦略です.

キーワード:
複雑な高リスクの冠動脈介入効能について主要な心血管および脳血管に関する有害事象安全性について静脈外膜の酸素化

さらに関連する動画

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

430
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

関連する実験動画

Last Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

430
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

科学分野:

  • 心血管医学
  • 介入心臓科
  • クリティカル ケア 医療

背景:

  • 高リスクの皮膚経冠動脈介入 (PCI) の予防的な静脈動脈外膜酸素化 (VA- ECMO) の証拠は限られている.
  • 複雑な冠動脈病変の患者は,しばしば重大な手順上のリスクに直面します.

研究 の 目的:

  • 選択的なPCI中に予防的なVA- ECMOの安全性と有効性を評価する.
  • 予防的なVA- ECMOと併用したPCIを受けた患者の合併症率とSYNTAXスコアの低下を比較する.

主な方法:

  • バイパス手術を拒否した,高リスクの冠動脈損傷 (SYNTAXスコア ≥33) を有する70人の患者による単一センターランダム化試験.
  • 患者はPCI前に予防用VA- ECMO (n=34) または対照群 (n=36) に割り当てられました.
  • 主要評価項目はPCI後の合併症率とSYNTAXスコアの低下でした.

主要な成果:

  • 予防的なVA- ECMO群では,生命を脅かす合併症の割合が著しく低下しました (0%対19. 4%,P=0. 01).
  • 緊急のVA-ECMOは,対照群の19. 4%で必要でした.
  • VA- ECMOグループは,SYNTAXスコアがより大きく低下した (27. 2対22. 5,P=0. 04).

結論:

  • 予防的なVA- ECMOは,高リスクのPCIにおける生命を脅かす合併症の減少と関連しています.
  • この戦略は,SYNTAXスコアで測定された冠動脈病変の複雑さをより顕著に減少させます.
  • これらの発見を確認し,管理戦略を最適化するために,さらなる大規模な研究が必要である.